DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20183380

Asthma management in pediatric age group

Mohammid Alzain, Hatem Mulla, Elaf Junainah, Abdullah Alasmari, Njood Albangali, Raneem Alqaedi, Hamad Al-yami, Fahad Alhawas, Amjad Allogmani, Malak Alfaifi

Abstract


Asthma is one of the most prevalent chronic illnesses that affect the pediatric population, defined as chronic airway inflammation, remodeling of the airway wall, and airway hyper-responsiveness to leading to spasms in response to stimuli inducing a reversible airflow obstruction. The death rate from asthma around the world is as high as 0.7 per 100,000 children, therefore making it important to understand all aspect of its pathophysiology and management. We conducted this review using a comprehensive search of Pubmed, MEDLINE, and EMBASE from March 1980, through November 2017. The following search terms were used: asthma pathophysiology, chemokines, leukotriene, asthma management, steroids, beta agonist, leukotriene modifiers. Our aim was to understand detailed pathophysiology of pediatric asthma, and also have a look at the management of asthma. Optimal management of pediatric asthma is based upon a variety of measures, such as good symptomatic control, drug therapy, inhalers, but more importantly what matters is a good relationship of the physician with the patient and their care takers in order to achieve better result in short and long term. The impact of the relationship must be studied in more details to make asthma management more efficient for the pediatric group of patients.


Keywords


Pediatric asthma, Asthma pathophysiology, Leukotriene modifiers for asthma management

Full Text:

PDF

References


Herzog R, Cunningham-Rundles S. Pediatric asthma: natural history, assessment, and treatment. Mt Sinai J Med. 2011;78:645-60.

Shea KM, Lash TL, Antonsen S, Jick SS, Sorensen HT. Population-based study of the association between asthma and pneumococcal disease in children. Clin Epidemiol. 2015;7:325-34.

Sibbald B. Extrinsic and intrinsic asthma:influence of classification on family history of asthma and allergic disease. Clin Allergy. 1980;10:313-8.

Globe G, Martin M, Schatz M, Wiklund I, Lin J, von Maltzahn R, et al. Symptoms and markers of symptom severity in asthma--content validity of the asthma symptom diary. Health Qual Life Outcomes. 2015;13:21.

Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma. Front Microbiol. 2013;4:263.

Keglowich LF, Borger P. The Three A's in Asthma - Airway Smooth Muscle, Airway Remodeling & Angiogenesis. Open Respir Med J. 2015;9:70-80.

Steinman RM, Koide S, Witmer M, Crowley M, Bhardwaj N, Freudenthal P, et al. The sensitization phase of T-cell-mediated immunity. Ann N Y Acad Sci. 1988;546:80-90.

Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002;17:375-87.

Busse WW. The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy. 1996;26:868-79.

Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346:1699-705.

Bradding P. Asthma: eosinophil disease, mast cell disease, or both? Allergy Asthma Clin Immunol. 2008;4:84-90.

Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol. 2006;117:1277-84.

Possa SS, Leick EA, Prado CM, Martins MA, Tiberio IF. Eosinophilic inflammation in allergic asthma. Front Pharmacol. 2013;4:46.

Hrusch CL, Tjota MY, Sperling AI. The role of dendritic cells and monocytes in the maintenance and loss of respiratory tolerance. Curr Allergy Asthma Rep. 2015;15:494.

Reeves SR, Kolstad T, Lien TY, Herrington-Shaner S, Debley JS. Fibroblast-myofibroblast transition is differentially regulated by bronchial epithelial cells from asthmatic children. Respir Res. 2015;16:21.

Ercan H, Birben E, Dizdar EA, Keskin O, Karaaslan C, Soyer OU, et al. Oxidative stress and genetic and epidemiologic determinants of oxidant injury in childhood asthma. J Allergy Clin Immunol. 2006;118:1097-104.

Fehrenbach H, Wagner C, Wegmann M. Airway remodeling in asthma:what really matters. Cell Tissue Res. 2017;367:551-69.

Singh RK, Tandon R, Dastidar SG, Ray A. A review on leukotrienes and their receptors with reference to asthma. J Asthma. 2013;50:922-31.

Reddy AP, Gupta MR. Management of asthma:the current US and European guidelines. Adv Exp Med Biol. 2014;795:81-103.

Chhabra SK. Clinical application of spirometry in asthma:Why, when and how often? Lung India. 2015;32:635-7.

Bone RC. Goals of asthma management. A step-care approach. Chest. 1996;109:1056-65.

Wechsler ME. Managing asthma in primary care:putting new guideline recommendations into context. Mayo Clin Proc 2009;84:707-17.

23. McCracken JL, Veeranki SP, Ameredes BT, Calhoun WJ. Diagnosis and Management of Asthma in Adults: A Review. JAMA. 2017;318:279-90.

Tan H, Sarawate C, Singer J, Elward K, Cohen RI, Smart BA, et al. Impact of asthma controller medications on clinical, economic, and patient-reported outcomes. Mayo Clin Proc. 2009;84:675-84.

Sobande PO, Kercsmar CM. Inhaled corticosteroids in asthma management. Respir Care. 2008;53:625-33;discussion 33-4.

Kuzik BA. Inhaled corticosteroids in children with persistent asthma: Effects on growth. Paediatr Child Health. 2015;20:248-50.

Hossny E, Rosario N, Lee BW, Singh M, El-Ghoneimy D, Soh JY, et al. The use of inhaled corticosteroids in pediatric asthma:update. World Allergy Organ J. 2016;9:26.

Price D, Dale P, Elder E, Chapman KR. Types, frequency and impact of asthma triggers on patients' lives:a quantitative study in five European countries. J Asthma. 2014;51:127-35.

Butz AM, Walker JM, Pulsifer M, Winkelstein M. Shared decision making in school age children with asthma. Pediatr Nurs. 2007;33:111-6.